Fermentation Derived HMO HMO-009

Description

Product Overview

Fermentation Derived HMO HMO-009 is a high-value human milk oligosaccharide (HMO) produced through advanced microbial fermentation technology, designed for use in premium infant nutrition, functional foods, and specialized nutritional formulations. It provides a structurally identical alternative to naturally occurring HMOs found in human breast milk, supporting the development of next-generation nutritional products. With scalable biotechnological production, this ingredient enables manufacturers to meet growing global demand for scientifically advanced, clean-label, and evidence-based nutrition solutions. Its strategic importance lies in expanding access to innovative infant and health nutrition products through reliable and sustainable supply chains.

Key Specifications & Technical Characteristics

• Chemical Composition / Material Components: Human Milk Oligosaccharide (HMO) produced via precision microbial fermentation; typically includes specific HMO structures such as 2’-Fucosyllactose (2’-FL) depending on product specification.
• Purity Level / Grade: Food-grade or infant nutrition-grade; high purity with controlled microbial fermentation and purification processes.
• Physical Characteristics:
  • Form: Fine powder
  • Color: White to off-white
  • Odor: Neutral or characteristic mild sweetness
  • Solubility: Highly soluble in water
  • Moisture Content: Controlled to maintain stability and quality
• Packaging Options: 5 kg, 10 kg, 25 kg aluminum foil bags or food-grade fiber drums; customized bulk packaging available for industrial requirements.
• Shelf Life: Typically 24–36 months when stored in a cool, dry environment under recommended conditions.
• Storage Conditions: Store sealed, protected from moisture, heat, and direct sunlight.

Core Industrial Applications

• Infant Nutrition Industry: Used as a premium functional ingredient in infant formulas to replicate key nutritional components naturally present in human milk.
• Functional Food & Beverage Manufacturing: Incorporated into health beverages, nutritional powders, and wellness products targeting digestive and immune health.
• Dietary Supplement Industry: Used in advanced formulations supporting microbiome balance and nutritional enhancement.
• Clinical Nutrition Applications: Applied in specialized nutritional products requiring scientifically validated bioactive ingredients.

Fermentation-derived HMO provides superior scalability, consistent quality, and supply reliability compared with extraction-based alternatives, enabling manufacturers to achieve stable production volumes while maintaining strict nutritional and safety standards.

Competitive Advantages

• Quality Consistency: Advanced fermentation and purification technology ensures batch-to-batch uniformity and reliable functional performance.
• Supply Reliability: Scalable biotechnology production supports long-term industrial supply agreements and global demand growth.
• Logistics Capability: Available in export-ready packaging with documentation support for international food and nutrition supply chains.
• Price Competitiveness: Efficient fermentation production provides cost advantages compared with limited natural extraction methods.
• Sustainability Benefits: Biotechnology-based manufacturing reduces dependence on animal-derived sources and supports environmentally responsible ingredient production.
• Technical Support & Documentation: Available with quality certificates, specification sheets, safety documentation, and regulatory support for commercial applications.

Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20 MT
• Loading Capacity (MT per Container): Approximately 20–25 MT per 20-foot container depending on packaging configuration and shipment requirements.